| ACTB |
P60709
|
actin beta
|
Cellular structure
|
0.99 |
0.325 |
0.923 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| COL11A2 |
P13942
|
collagen type XI alpha 2 chain
|
|
0.70 |
0.435 |
0.846 |
| CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
| EP300 |
Q09472
|
E1A binding protein p300
|
|
1.00 |
0.459 |
0.846 |
| GPER1 |
Q99527
|
G protein-coupled estrogen receptor 1
|
G-protein coupled receptor
|
0.57 |
0.505 |
0.731 |
| HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
| JAK1 |
P23458
|
Janus kinase 1
|
Kinase
|
1.00 |
0.474 |
0.769 |
| KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
| KMT2D |
O14686
|
lysine methyltransferase 2D
|
|
1.00 |
0.465 |
0.808 |
| NADSYN1 |
Q6IA69
|
NAD synthetase 1
|
|
1.3E-16 |
0.780 |
0.231 |
| NF1 |
P21359
|
neurofibromin 1
|
Enzyme modulator
|
0.90 |
0.440 |
0.885 |
| NHS |
Q6T4R5
|
NHS actin remodeling regulator
|
|
1.00 |
0.466 |
0.846 |
| NMNAT2 |
Q9BZQ4
|
nicotinamide nucleotide adenylyltransferase 2
|
Enzyme
|
0.99 |
0.670 |
0.500 |
| NOTCH1 |
P46531
|
notch receptor 1
|
|
1.00 |
0.369 |
0.885 |
| NTRK1 |
P04629
|
neurotrophic receptor tyrosine kinase 1
|
Kinase
|
2.0E-06 |
0.422 |
0.808 |
| PIK3CA |
P42336
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
|
Kinase
|
1.00 |
0.292 |
0.923 |
| PRF1 |
P14222
|
perforin 1
|
|
5.5E-06 |
0.540 |
0.692 |
| PTEN |
P60484
|
phosphatase and tensin homolog
|
Enzyme
|
0.26 |
0.305 |
0.923 |
| PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
| PUF60 |
Q9UHX1
|
poly(U) binding splicing factor 60
|
|
1.00 |
0.536 |
0.769 |
| RAF1 |
P04049
|
Raf-1 proto-oncogene, serine/threonine kinase
|
Kinase
|
0.85 |
0.418 |
0.885 |